Sirolimus and Immunoglobulin Replacement Therapy in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS): A Systematic Literature Review
Nicholas L. Hartog, Konrad Pisarczyk, Mike Samad, Katerina Vlachopoulou, Amanda Harrington
Springer Nature ·
2026-10-26
· DOI 10.1007/s12325-026-03833-8
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Nicholas L. Hartog, Konrad Pisarczyk, Mike Samad, Katerina Vlachopoulou, Amanda Harrington. Sirolimus and Immunoglobulin Replacement Therapy in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS): A Systematic Literature Review. // Advances in Therapy. – 2026. – DOI: 10.1007/s12325-026-03833-8. – URL: https://doi.org/10.1007/s12325-026-03833-8
Nicholas L. Hartog, Konrad Pisarczyk, Mike Samad, Katerina Vlachopoulou, & Amanda Harrington (2026). Sirolimus and Immunoglobulin Replacement Therapy in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS): A Systematic Literature Review. Advances in Therapy. https://doi.org/10.1007/s12325-026-03833-8
Nicholas L. Hartog, et al. “Sirolimus and Immunoglobulin Replacement Therapy in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS): A Systematic Literature Review.” Advances in Therapy, 2026. doi:10.1007/s12325-026-03833-8.
@article{Hartog2026,
title = {Sirolimus and Immunoglobulin Replacement Therapy in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS): A Systematic Literature Review},
author = {Hartog, Nicholas L. and Pisarczyk, Konrad and Samad, Mike and Vlachopoulou, Katerina and Harrington, Amanda},
journal = {Advances in Therapy},
year = {2026},
doi = {10.1007/s12325-026-03833-8},
url = {https://doi.org/10.1007/s12325-026-03833-8}
}